1. A phase I study of the MDM2 antagonist RO6839921, a pegylated prodrug of idasanutlin, for intravenous (IV) administration in patients with advanced solid tumors. (December 2016) Authors: Razak, A.; Gore, L.; Britten, C.D.; Miller, W.H.; Uy, G.L.; Nichols, G.; Middleton, S.; Blotner, S.; Zhi, J.; Jukofsky, L.; Pierceall, W.; Higgins, B.; Chen, L.C. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Supernova neutrino detection in NOvA. Issue 10 (1st October 2020) Authors: Acero, M.A.; Adamson, P.; Agam, G.; Aliaga, L.; Alion, T.; Allakhverdian, V.; Anfimov, N.; Antoshkin, A.; Arrieta-Diaz, E.; Asquith, L.; Aurisano, A.; Back, A.; Backhouse, C.; Baird, M.; Balashov, N.; Baldi, P.; Bambah, B.A.; Bashar, S.; Bays, K.; Bending, S. Journal: Journal of cosmology and astroparticle physics Issue: Volume 2020:Issue 10(2020) Page Start: 014 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗